Ifp Advisors, Inc Gamida Cell Ltd. Transaction History

Ifp Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$0.0 - $0.04 $0 - $80	2,000 Added 1000.0%	2,200 $0
Q2 2022 Sep 06, 2022	BUY	$1.73 - $4.29 $346 - $858	200 New	200 $2,000
Q2 2022 Aug 12, 2022	SELL	$1.73 - $4.29 $346 - $858	-200 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$7.8 - $12.43 $1,560 - $2,486	200 New	200 $2,000

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.